After Pfizer's COVID vaccine was administered in the UK, two allergic reactions surfaced. Who’s to blame? The drug maker? I argue no. Pfizer could not possibly have known in advance whether these reactions would occur or, if so, how frequently. Why's that? Here's why.
Drugs & Pharmaceuticals
Toilet paper always flies off the shelves when there's a crisis, whether it's real or perceived. But after nine months of COVID, there's a new "panic item": antacids. Here's why.
A study by a group from the Mayo Clinic in Arizona focuses on making it easier to dispose of unused opioid pills. I would argue that we need better disposal methods for opioids like a fulminating case of crabs. Here are both sides of the debate.
More than six months after the hype of repurposed COVID drugs, we have nothing. But this wasn't at all unexpected. Here's why.
Eric Topol is a cardiologist working in translational medicine, innovation, at Scripps Clinic in San Diego. He is an active commentator in healthcare. Here is his Twitter thread on Operation Warp Speed along with the vaccine development timeline.
A recent NPR article discussed the business of fentanyl synthesis in China. But it's not just fentanyl. There is a cottage industry in making and selling some of the chemicals that are used to synthesize the drug. What would happen if some of the chemicals that are used to synthesize the drug were banned? Would this shut down its production?
Pfizer and Moderna are producing fewer but more effective (and pricier) vaccines, while AstraZeneca is making a greater number of less effective (and cheaper) vaccines.
We got some very good news in the past week. Vaccines from Pfizer and Moderna greatly exceeded expectations. But Drs. Seley-Radtke and Bloom argue in the Duluth News Tribune that antiviral drugs will still be needed, no matter how good the vaccines are.
We've just gotten a whole bunch of good news – news we really needed – about finally getting the upper hand against COVID-19. Two vaccines, both more than 90% effective at protecting clinical trial participants against the disease, were announced just seven days apart. These numbers are well beyond expectations, but some critically important questions linger. Here they are. The answers will determine how successful the vaccines will be.
Should people who were given propofol be allowed to drive home? Are men drivers better or worse than women? Some ghastly chemistry poetry, and one of the funniest YouTube videos ever. Oh, to answer the original question: it's impossible to tell from this study. Here's why.
Purdue Pharma will pay an $8 billion fine and shut down. Finally, justice has been served, though far too late for the thousands of addicted or dead Americans whose problems began with OxyContin.
There was never much evidence in favor of using hydroxychloroquine (HCQ) as a treatment for COVID. Now, a trial involving over 4,700 patients definitively proves that HCQ does not work.